Bivalirudin
The Medicines Company
['cardio']
bivalirudin is a safer and more effective anticoagulant than heparin for treating heart attack patients undergoing percutaneous coronary intervention (pci), according to a new study led by dr. : #aha22 #cardiotwitter 
An international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for @MountSinaiNYC.